Kimberly Broomfield
Family · Dallas, TXNPI 1306347307
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 38 manufacturers reported payments, led by AbbVie at 34.3% of the total. Reporting peaked in 2022 at $979 and has fallen 97.3% since, to $26 in 2024.
Across 159 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$886
- Neurocrine Biosciences, Inc.$139
- Boston Scientific$137
- UCB, Inc.$124
- Sunovion Pharmaceuticals Inc.$88
- Biogen$86
- plus $1K from 32 others
What the payments were for
- Speaking & faculty fees$261%
- Food & beverage$2,55599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,581 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Other family in Dallas
- David WeirDallas$959K
- Sie ThomasDallas$197K
- Marcia HarrisDallas$156K
- Miles HortonDallas$72K
- Natasha SimmonsDallas$38K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.